Interesting, they use a chimeric agent instead of steroids. I never researched the competition. So, never came across this.
So why the difference, anyone here familiar with basiliximab. Obviously, it is more likely to have more side effects than steroids. Is it, because of the il-2 receptor?
The only thing that comes across to me is that they are still doing mouse studies. (human/mouse) chimeric antibody.
I'm kidding!!! Chill Doc
Cell Therapy News/Articles, page-17809
-
- There are more pages in this discussion • 454 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |